Tag: covid-19

5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials

5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials

HIT Consultant

Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…

Continue Reading
Monday Morning Update 2/20/23

Monday Morning Update 2/20/23

HIStalk

Top News

The VA postpones its planned July 2023 Oracle Cerner go-live at its Ann Arbor, MI facilities until later this year or early in 2024.
The service region is concerned about “how well EHRM would interact with VA Ann Arbor’s vital medical research mission.”

Reader Comments From AT: “Re: pet peeves with service industry words and phrases. ‘I appreciate you,’ following my thanking you and leaving you a tip, which suggests that we are like-minded, decent people even though you have no way of knowing that. Second is thanking someone with ‘of course,” implying that I’m either too stupid to know…

Continue Reading
Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

MedCity News

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…

Continue Reading
Q&A: Thrive Center’s CEO Makes Staffing Shortage Concerns a Top Priority

Q&A: Thrive Center’s CEO Makes Staffing Shortage Concerns a Top Priority

HealthTech Magazine

HEALTHTECH: What are the highest-priority issues for senior care organizations in 2023?ROSE: I think it would be workforce and staffing issues, especially in the post-acute area. Unfortunately, because of the COVID-19 pandemic, we saw so many people leave healthcare. Staffing has always been an issue, but it reached critical status during the pandemic. Now, organizations are really trying to recover, so they’re looking for solutions that can augment their workforce and make workflows seamless — not a lot of logins, not a lot of devices, more cloud-based solutions that will really drive efficiency and mobility, because that’s going to be key to a…

Continue Reading
Retrieving Billions in Overpayments by CMS

Retrieving Billions in Overpayments by CMS

Healthcare IT Today

Amid swirling accusations that Medicare Advantage Organizations (MAOs) are overbilling the U.S. government and calls for better oversight, the Centers for Medicare & Medicaid Services announced in early February that it would investigate overbilling by those plans. They expect to recoup 4.7 billion dollars through this program.
This article focuses on the relatively young technologies that enable CMS to uncover overbillings, whether they be errors or fraud. The article is based on an interview with Kel Pults, chief clinical officer and vice president of MediQuant. A future article will explain how Medicare Advantage plans are trying to improving data collection and reporting,…

Continue Reading
The Adderall Shortage

The Adderall Shortage

MedCity News

The current Adderall shortage is of serious concern to both patients who have attention deficit hyperactivity disorder (ADHD) and clinicians. This shortage cannot be quickly alleviated by a simple increase in the amount of medication manufactured, unless the upper limit to the amount of Adderall’s active ingredient that can be manufactured in a given year is raised by the Drug Enforcement Agency (DEA). The limit has been imposed because the active ingredient can be abused as a recreational drug. It is necessary to control the supply of any medication with abuse liability, but this must be achieved without compromising the legitimate…

Continue Reading
Leveraging Technology to Bridge Gaps in Compliance

Leveraging Technology to Bridge Gaps in Compliance

HIT Consultant

Sean Eaton, Senior Compliance Solutions Specialist at GHXAmerican health systems, hospitals and post-acute care providers are required to comply with hundreds of regulatory requirements. Facilitating this compliance comes with a high cost. According to the American Hospital Association, the average-sized community hospital spends nearly $7.6 million annually on administrative activities to support regulatory compliance. With the impending end of the COVID-19 public health emergency set to shake up healthcare regulations, ongoing healthcare labor shortages, and skyrocketing levels of clinician burnout, a perfect storm for non-compliance is brewing. Even with significant investments in administration to support compliance, overwhelmed providers can inadvertently leave gaps…

Continue Reading
How to Rein in Unpredictability During High-Traffic Respiratory Illness Season

How to Rein in Unpredictability During High-Traffic Respiratory Illness Season

MedCity News

‘Tripledemic’ concerns have been on the rise with the collision of flu, Covid-19, and respiratory syncytial virus (RSV) wreaking havoc in clinics and hospitals. Yet staff are expected to provide smooth, fast, and effective care journeys for all, no matter the volume of patients. We know, however, that everything doesn’t always go as planned when patient traffic explodes. Bottlenecks like long wait times and limited appointment options inevitably skyrocket, and staff bear the brunt of patients who (understandably) want to be seen immediately, in conjunction with staff members intermittently being out sick themselves.
Living in an environment of extreme health unpredictability affects…

Continue Reading
RTLS & AI: Solving the Riddle of Healthcare Inefficiency

RTLS & AI: Solving the Riddle of Healthcare Inefficiency

Healthcare IT Today

The following is a guest article by Steven Manifold, CMO at Ubisense.
Many healthcare systems around the world are overburdened. Some face the lingering effects of COVID-19, while others lack funding and staff. Healthcare providers are increasingly turning to technology to help shoulder these burdens, but are fancy tech deployments really the cure or just another placebo?   
RTLS
RTLS (Real-time Location Systems) are not new technologies, but they remain uncommon in most healthcare settings. Popular in automotive, aerospace, and general manufacturing and logistics industries, they have paved the way towards smarter, more efficient industrial practices while contributing to the much vaulted “Industry 4.0” revolution….

Continue Reading
Report: Pharma R&D ROI Falls to Lowest Level in 13 Years

Report: Pharma R&D ROI Falls to Lowest Level in 13 Years

HIT Consultant

What You Should Know:– Deloitte Centre for Health Solutions releases its thirteenth annual report, ‘Seize the Digital Momentum: Measuring the return from pharmaceutical innovation 2022’ that explores the performance of the biopharmaceutical industry (bio Pharma) and its ability to generate returns from investment in innovative new medicines.– Since 2021, much of the world has successfully adjusted to life where COVID-19 is more endemic as vaccines and treatments reduced the risk and severity of illness, however geopolitical turmoil and a global cost-of-living crisis have continued to drive serious instability in the health landscape.Pharmaceutical Innovation – Trends and Insights At a GlanceThis is…

Continue Reading